GNRH1 and posterior cortical atrophy: Schally and colleagues reported that patients with advanced PCa who were administered daily doses of LHRH agonists experienced a 75% reduction in serum testosterone levels, regularization of phosphatase levels in plasma acid, and, most significantly, substantial alleviation of bone pain from metastasized PCa [5].